### Institutional Regulations and Policies for Clinical Trials

#### 1. **General Eligibility Criteria**
   - **Age Restrictions**: Patients must be between 18 and 75 years old.
   - **Gender**: No restrictions unless specified by the trial protocol.
   - **Informed Consent**: All patients must provide informed consent prior to participation.
   - **Residency**: Patients must be residents of the country where the trial is conducted.
   - **Health Insurance**: Patients must have valid health insurance coverage.

#### 2. **Medical History Restrictions**
   - **Severe Heart Disease** (e.g., recent myocardial infarction, heart failure)
   - **Uncontrolled Diabetes Mellitus**     
   - **Recent Surgeries**: Patients who have undergone major surgery within the current year are not eligible.   
   - **Infectious Diseases**: Patients with active tuberculosis, hepatitis B or C, or HIV are excluded unless the trial is specifically designed for these conditions.

#### 3. **Previous Trial Participation**   
   - **Trial Frequency**: Patients should not have participated in more than two clinical trials in the past year excluding this trial to prevent overexposure to experimental treatments.
   - **Active Trials**: Patients currently enrolled in another active trial are not eligible until they have completed or withdrawn from the ongoing trial.
   - **Recent Trials**: Patients cannot have participated in any other clinical trial within the past 5 months from now.
   - **Trial Outcomes**:
     - Patients who were withdrawn from previous trials due to adverse effects are not eligible.
     - Patients who have completed a trial must have a documented recovery period before participating in a new trial.

#### 4. **Medication and Treatment Restrictions**
   - **Concurrent Medications**: Patients must not be on any medication that could interfere with the study drug, unless specified by the trial protocol.
   - **Substance Abuse**: Patients with a history of substance abuse within the past 12 months are excluded.
   - **Vaccinations**: Patients must not have received live vaccines within 30 days prior to the start of the trial.

#### 5. **Regulatory Compliance**
   - **Ethics Approval**: All trials must have approval from the Institutional Review Board (IRB) or Ethics Committee.
   - **Data Privacy**: Patient data must be handled in compliance with data protection regulations (e.g., GDPR, HIPAA).
   - **Adverse Event Reporting**: Any adverse events must be reported according to institutional and regulatory guidelines.

#### 6. **Special Considerations**
   - **Pregnancy and Nursing**: Pregnant or nursing women are excluded unless the trial is specifically designed for this population.
   - **Genetic Testing**: Trials involving genetic testing must have explicit consent from patients for genetic data collection and analysis.
   - **Patient Monitoring**: Patients must agree to regular monitoring and follow-up visits as specified by the trial protocol.
   - **BMI Restrictions**: Patients with a BMI outside the range of 18.5-35 may be excluded unless otherwise specified.
   - **Comorbid Conditions**: Patients with multiple comorbid conditions that may interfere with the study outcomes are excluded.

#### 7. **Emergency Contact and Support**
   - **Emergency Contact**: Patients must provide emergency contact information.
   - **Support Systems**: Patients must have access to appropriate support systems (e.g., caregiver, family member) to assist them throughout the trial.

#### 8. **Travel Restrictions**
   - **Travel Requirements**: Patients must be able to travel to the trial site regularly for check-ups and monitoring without significant hardship or risk.
   - **Travel History**: Patients who have traveled to areas with active outbreaks of infectious diseases within the past 3 months are not eligible.

#### 9. **Dietary and Lifestyle Restrictions**
   - **Dietary Compliance**: Patients must adhere to any dietary restrictions or requirements specified by the trial protocol.
   - **Lifestyle Modifications**: Patients must be willing to comply with lifestyle modifications required by the trial protocol, such as exercise regimens or smoking cessation.

#### 10. **Allergies and Sensitivities**
   - **Allergy Disclosure**: Patients must disclose any known allergies or sensitivities, particularly to medications, foods, or environmental factors.
   - **Medication Sensitivity**: Patients with known sensitivities to medications being tested in the trial are excluded.

#### 11. **Cognitive and Communication Abilities**
   - **Cognitive Assessment**: Patients must have the cognitive ability to understand and comply with the trial protocol and instructions.
   - **Communication Abilities**: Patients must be able to effectively communicate with the research team and understand instructions, either directly or with the assistance of a caregiver.

#### 12. **Employment and Daily Responsibilities**
   - **Employment Impact**: Patients must disclose if participation in the trial could impact their employment or daily responsibilities significantly.
   - **Availability**: Patients must be available for all scheduled trial visits and assessments as required by the protocol, with minimal risk of missing appointments.